Taconic Biosciences

Taconic Biosciences

Ry, Denmark· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Taconic Biosciences is a privately held, Denmark-based company that is a leading enabler of preclinical drug discovery through its specialized portfolio of genetically engineered rodent models and research services. It operates as a critical service provider to the biopharma industry, offering both off-the-shelf and custom models that help researchers validate targets and test therapeutic candidates in vivo. With a global operational footprint and a focus on model quality and standardization, the company occupies a key niche in the research tools ecosystem. Its business model is built on recurring service revenue from model licensing, breeding, and related support, rather than developing its own therapeutic pipeline.

OncologyImmunologyMetabolic DiseaseNeuroscience

Technology Platform

Advanced genetic engineering platform for creating and supplying genetically engineered mouse and rat models (e.g., knockouts, knock-ins, humanized models). Integrated services include model generation (custom and off-the-shelf), breeding, health monitoring, cryopreservation, and rederivation to support the entire research model lifecycle.

Funding History

1
Private EquityUndisclosed

Opportunities

Growth is driven by increasing R&D in complex fields like immuno-oncology and cell therapy, which require sophisticated humanized animal models.
The trend towards personalized medicine and the continued need for high-fidelity in vivo data present significant opportunities for portfolio expansion and premium services.
Strategic acquisitions can further consolidate its market position.

Risk Factors

Faces competition from other large model providers and disruptive non-animal technologies.
Operational risks include disease outbreaks in breeding colonies.
Regulatory changes and societal pressure concerning animal welfare could increase costs and limit certain research applications.

Competitive Landscape

Taconic operates in a competitive market with major players like The Jackson Laboratory (non-profit) and Charles River Laboratories (public). It differentiates through a focused portfolio of genetically engineered models, a strong reputation for quality and standardization, and a global service footprint. Competition is based on model portfolio breadth, scientific expertise, price, and service quality.